[Risk factors for failure of pre-cut eye bank UT-DSAEK grafts].

Évaluation des greffes UT-DSAEK prédécoupées en banque multi-tissus.

Journal

Journal francais d'ophtalmologie
ISSN: 1773-0597
Titre abrégé: J Fr Ophtalmol
Pays: France
ID NLM: 7804128

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 28 12 2021
revised: 26 07 2022
accepted: 15 08 2022
medline: 31 3 2023
pubmed: 22 2 2023
entrez: 21 2 2023
Statut: ppublish

Résumé

The main risk factors for graft failure in penetrating keratoplasty are well known. However, few studies have examined donor characteristics or more precise data on endothelial keratoplasty. This was a retrospective, single-center study at the Nantes University Hospital, aiming to identify factors predictive of one-year success or failure of eye bank UT-DSAEK endothelial keratoplasty grafts prepared between May 2016 and October 2018. The outcome measure was success or failure at 12months post keratoplasty. One hundred and five grafts were included: 93 successes and 12 failures at 12months. The failure rate was higher in 2016 compared to 2017 and 2018. The characteristics associated with higher failure rate were elderly donor, shorter time between harvesting and grafting, lower endothelial cell density, significant pre-graft endothelial cell loss, re-graft for Fuchs dystrophy, history of corneal transplant. Our results are consistent with those in the literature. However, some factors, such as the type of corneal harvesting or pre-graft endothelial cell loss, were not found. UT-DSAEK has demonstrated better results than DSAEK, but still appears to be somewhat inferior to DMEK. The main factor for graft failure in our study was an early re-graft within 12months. However, the low incidence of graft failure limits interpretation of these results.

Identifiants

pubmed: 36804114
pii: S0181-5512(23)00029-3
doi: 10.1016/j.jfo.2022.08.012
pii:
doi:

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

311-321

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Auteurs

F Bodénès (F)

Clinique ophtalmologique, CHU de Nantes, 1, place Alexis - Ricordeau, 44000 Nantes, France. Electronic address: florian.bodenes@chu-nantes.fr.

Y Eude (Y)

Clinique ophtalmologique, CHU de Nantes, 1, place Alexis - Ricordeau, 44000 Nantes, France.

M Baud'huin (M)

Banque multi-tissus, CHU de Nantes, 9, quai Moncousu, 44000 Nantes, France.

B Vabres (B)

Clinique ophtalmologique, CHU de Nantes, 1, place Alexis - Ricordeau, 44000 Nantes, France.

M Weber (M)

Clinique ophtalmologique, CHU de Nantes, 1, place Alexis - Ricordeau, 44000 Nantes, France.

G Le Meur (G)

Clinique ophtalmologique, CHU de Nantes, 1, place Alexis - Ricordeau, 44000 Nantes, France.

I Orignac (I)

Clinique ophtalmologique, CHU de Nantes, 1, place Alexis - Ricordeau, 44000 Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH